Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.59 |
| ▸ | CDK2 | P24941 | 2/20 | 0.46 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.46 |
| ▸ | PAK1 | Q13153 | 1/20 | 0.44 |
| ▸ | CCNT1 | O60563 | 1/20 | 0.39 |
| ▸ | CDK1 | P06493 | 1/20 | 0.39 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.39 |
| ▸ | CDK7 | P50613 | 1/20 | 0.39 |
| ▸ | CDK9 | P50750 | 1/20 | 0.39 |
| ▸ | CCNH | P51946 | 1/20 | 0.39 |
| ▸ | POLA1 | P09884 | 1/20 | 0.37 |
| ▸ | SCD | O00767 | 2/20 | 0.32 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.31 |
| ▸ | GDA | Q9Y2T3 | 1/20 | 0.31 |
| ▸ | GLA | P06280 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL316720 | 0.98 | ALDH1A1 (0.57) | ALDH1A1KDM4ECDK2RXFP1PAK1 | |
| Hydrochloric Acid SCHEMBL28253846 | 0.98 | ALDH1A1 (0.57) | ALDH1A1KDM4ECDK2RXFP1PAK1 | |
| Ammonia Solution, Strong SCHEMBL27831351 | 0.98 | ALDH1A1 (0.57) | ALDH1A1KDM4ECDK2RXFP1PAK1 | |
| SCHEMBL671499 | 0.98 | ALDH1A1 (0.57) | ALDH1A1KDM4ECDK2RXFP1PAK1 | |
| SCHEMBL11039497 | 0.98 | ALDH1A1 (0.57) | ALDH1A1KDM4ECDK2RXFP1PAK1 | |
| Pyrimidine SCHEMBL29199390 | 0.88 | ALDH1A1 (0.47) | ALDH1A1KDM4ECDK2RXFP1PAK1 | |
| Purine SCHEMBL5315439 | 0.88 | ALDH1A1 (0.47) | ALDH1A1KDM4ECDK2RXFP1PAK1 | |
| Imidazole SCHEMBL28111160 | 0.85 | ALDH1A1 (0.45) | ALDH1A1KDM4ECDK2RXFP1PAK1 | |
| SCHEMBL16752071 | 0.83 | KDM4E (0.44) | ALDH1A1KDM4ECDK2RXFP1PAK1 | |
| Mercaptopurine Anhydrous SCHEMBL5534039 | 0.83 | ALDH1A1 (0.44) | ALDH1A1KDM4ECDK2RXFP1PAK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 114886 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3607938-B1 | PHARMACEUTICAL COMPOSITION | SOVIC BRKICIC LJILJANA (HR) | 2026-05-27 | — | — | EP | claimed |
| EP-4747263-A1 | LIPID NANOPARTICLES AND USES THEREOF | University of Connecticut (US) | 2026-05-27 | — | — | EP | claimed |
| EP-4748859-A2 | CHEMICALLY AND PHOTOCHEMICALLY INITIATED CELL MEMBRANE BLEBBING TO INDUCE CELL VESICLE PRODUCTION, MODIFICATIONS THEREOF, AND USES THEREOF | The Regents of the University of California (US) | 2026-05-27 | — | — | EP | claimed |
| CN-116209439-B | Cereblon protein modulators | Saint Jude Children's Research Hospital Ltd. (US) | 2026-05-26 | — | — | CN | claimed |
| CN-122075497-A | Use of NLRP3 agonist for tumor treatment | — | 2026-05-26 | — | — | CN | claimed |
| US-20260137700-A1 | PHARMACEUTICAL COMBINATION OF PRMT5 INHIBITOR AND DNA DAMAGE-INDUCING SUBSTANCE | SK BIOPHARMACEUTICALS CO LTD (KR) | 2026-05-21 | — | — | US | claimed |
| US-20260139320-A1 | StarTrace: A Multiplex Drug Testing Platform for Personalized Medicine | UNIV OF SOUTH CAROLINA (US) | 2026-05-21 | — | — | US | claimed |
| WO-2026107377-A1 | PHARMACOLOGICAL RE-ACTIVATION OF MUTANT PVHL | KARANICOLAS JOHN (US) | 2026-05-21 | — | — | WO | claimed |
| US-20260141455-A1 | LOCATION BASED DATABASE SYSTEM DASHBOARDS | EXPRESS SCRIPTS STRATEGIC DEV INC (US) | 2026-05-21 | — | — | US | claimed |
| WO-2026107140-A1 | METHODS FOR INDUCING ALLOGENEIC TISSUE ANTIGEN TOLERANCE | WAKE FOREST UNIVERSITY HEALTH SCIENCES (US) | 2026-05-21 | — | — | WO | claimed |
| EP-0073490-B1 | DIHYDROTHIAZOLE-PURINES | Newport Pharmaceuticals International, Inc. (US) | 1986-04-30 | — | — | EP | claimed |
| EP-0081882-B1 | MEDICINE HAVING TRANSPLANT REJECTION AND/OR IMMUNOLOGICAL INFLAMMATION INHIBITING ACTIVITIES, AS WELL AS A METHOD FOR INHIBITING TRANSPLANT REJECTION AND/OR IMMUNOLOGICAL INFLAMMATION | Erasmus Universiteit Rotterdam (NL) | 1986-04-16 | — | — | EP | claimed |
| EP-0169618-A2 | Method for making uniformly sized particles from water-insoluble organic compounds | STERILIZATION TECHNICAL SERVICES, Inc. (US) | 1986-01-29 | — | — | EP | claimed |
| EP-0120907-A1 | PHARMACEUTICAL PREPARATIONS FOR USE IN ANTITUMOUR THERAPY | Aston Molecules Limited (GB) | 1984-10-10 | — | — | EP | claimed |
| US-4452794-A | MIXTURE OF A PROSTAGLANDIN DERIVATIVE AND A CORTICOSTEROID OR A MERCAPTOPURINE | ERASMUS UNIVERSITEIT ROTTERDAM (NL) | 1984-06-05 | — | — | US | claimed |
| WO-1984001506-A1 | PHARMACEUTICAL PREPARATIONS FOR USE IN ANTITUMOUR THERAPY | UNIV BIRMINGHAM (GB) | 1984-04-26 | — | — | WO | claimed |
| EP-0081882-A1 | Medicine having transplant rejection and/or immunological inflammation inhibiting activities, as well as a method for inhibiting transplant rejection and/or immunological inflammation | Erasmus Universiteit Rotterdam (NL) | 1983-06-22 | — | — | EP | claimed |
| EP-0010964-A1 | Ravidomycin, process of preparation and pharmaceutical compositions containing same | AYERST, MCKENNA AND HARRISON INC. (CA) | 1980-05-14 | — | — | EP | claimed |
| US-4075021-A | COMPOUND WHICH RELEASES A SUBSTANCE WHICH PROMOTES BLEACHING OF DEVELOPED SILVER | KONISHIROKU PHOTO INDUSTRY CO., LTD. (JA) | 1978-02-21 | — | — | US | claimed |
| US-3939089-A | PEROXYSULFATE | TOKAI DENKA KOGYO KABUSHIKI KAISHA (JA) | 1976-02-17 | — | — | US | claimed |